Chemotherapy & More
- This forum has 1,019 topics, 3,393 replies, and was last updated 6 hours, 7 minutes ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
-
Our New Discussion Board is HERE
1
2
Started by:
in: Announcements
- 16
- 30
- 2 months, 3 weeks ago
- Success rate of microsatellite instability examination and complete response wit
- 1
- 1
- 6 hours, 7 minutes ago
- Adjuvant S-1 Versus Gemcitabine for Node-Positive Perihilar Cholangiocarcinoma:
- 1
- 1
- 3 days, 14 hours ago
- Efficacy of pembrolizumab in microsatellite instability-high locally advanced ch
- 1
- 1
- 1 week, 3 days ago
- Adjuvant S-1 Versus Gemcitabine for Node-Positive Perihilar Cholangiocarcinoma:
- 1
- 1
- 1 week, 3 days ago
- Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract canc
- 1
- 1
- 2 weeks, 2 days ago
- Phase II study of lenvatinib in combination with GEMOX chemotherapy for advanced
- 1
- 1
- 3 weeks, 2 days ago
- Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvati
- 1
- 1
- 3 weeks, 2 days ago
- Lenvatinib plus toripalimab as first-line treatment for advanced intrahepatic ch
- 1
- 1
- 3 weeks, 2 days ago
- FOENIX-CCA2 quality of life data for futibatinib-treated intrahepatic cholangioc
- 1
- 1
- 3 weeks, 2 days ago
- Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinom
- 1
- 1
- 3 weeks, 2 days ago
- [New European approvals: Pemigatinib – cholangiocarcinoma with a FGFR2 fusion or
- 1
- 1
- 1 month, 1 week ago
- Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and
- 1
- 1
- 1 month, 3 weeks ago
-
Our New Discussion Board is HERE
1
2
- You must be logged in to create new topics.